Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a mediterranean population: Interaction with tobacco smoking and the APOE locus

Journal of Lipid Research

Volumn 43, Issue 3, 2002, Pages 416-427

  Corella, Dolores ^a   Guillén, Marisa ^a   Sáiz, Carmen ^a   Portolés, Olga ^a   Sabater, Antonio ^a   Folch, José ^a   Ordovas, Jose M ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Apolipoprotein C III; Gene environmental interaction; Lipids; Lipoprotein lipase

Indexed keywords

APOLIPOPROTEIN C3; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEREDITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SPAIN;

ADULT; APOLIPOPROTEINS C; APOLIPOPROTEINS E; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DEOXYRIBONUCLEASE HINDIII; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; HUMANS; LIPIDS; LIPOPROTEIN LIPASE; MALE; POLYMORPHISM, GENETIC; SMOKING; SPAIN; TRIGLYCERIDES; VARIATION (GENETICS);

EID: 0036208675     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Coronary heart disease: At the interface of molecular genetics and preventive medicine
2. Interaction of diet and genes in atherogenesis: Report of an NHLBI working group
3. Fasting triglycerides, high density lipoprotein and risk of miocardial infarction
4. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease: A meta-analysis
5. Functional variants in the lipoprotein lipase gene and risk of cardiovascular disease
6. Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis
7. Lipoprotein lipase, a key role in atherosclerosis?
8. High density lipoprotein 2:Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase
9. Human genes involved in lipolysis of plasma lipoproteins: Mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21
10. Molecular pathobiology of the human lipoprotein lipase gene
11. Lipoprotein lipase gene variants and risk of coronary disease: A quantitative analysis of population-based studies
12. RFLP for human lipoprotein lipase gene (LPL): HindIII
13. Direct detection and automated sequencing of individual alleles after electrophoretic strand separation; Identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene
14. DNA polymorphisms at the lipoprotein lipase gene and their association with quantitative variation in plasma high-density lipoproteins and triacylglycerides
15. Linkage and association studies of the lipoprotein lipase gene with postheparine plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations: The HERITAGE Family Study
16. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease
17. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and post-prandial plasma triglycerides: The European Atherosclerosis Research Study (EARS)
18. The LPL HindIII RFLP: Association with TC and LDL-C, but not with HDL-C and TG in 342 females
19. Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: The Wandsworth Heart and Stroke Study
20. Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice
21. Apolipoprotein CIII polymorphism and coronary artery disease
22. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III
23. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus: Relationships with lipids, apolipoproteins, and premature coronary artery disease
24. Increased risk of endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism
25. Hypertriglyceridemia and the apolipoprotein CIII gene locus: Lack of association with the variant insulin response element in italian school children
26. Lack of association between genetic variations of apo A-I-CIII-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study
27. Apolipoprotein E polymorphism and atherosclerosis
28. Apolipoprotein E and atherosclerosis: Insight from animal and human studies
29. ApoE polymorphism and predisposition to coronary, heart disease in youths of different european populations: The EARS study
30. Modulation of plasma triglyceride levels by apoE phenotype: A meta-analysis
31. Apolipoprotein C-III displacement of apolioprotein E from VLDL: Effect of particle size
32. Characterizacion of recombinant wild type and site-directed mutations of apolipoprotein C-III: Lipid binding, displacement of apoE, and inhibition of lipoprotein lipase
33. Relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotein E polymorphism
34. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase
35. Smoking and plasma lipoprotein metabolism
36. The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin: Cholesterol acyl transferase activities in human plasma
37. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge
38. ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests
39. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
40. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population
41. Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France
42. DNA polymorphism haplotypes of human lipoprotein lipase gene: Possible association with high density lipoprotein levels
43. Iberia: Population genetics,anthropology, and linguistics
44. The burden of cardiovascular diseases mortality in Europe: Task Force of the European Society of Cardiology on cardiovascular mortality and morbility statistics in Europe
45. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms
46. An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population
47. Role of apolipoprotein CIII in triglyceriderich lipoprotein metabolism
48. Linkage disequilibrium of three polymorphic RFLP markers in the apolipoprotein AI-CIII gene cluster on chromosome 11
49. Common genetic variation in the promoter of the human apoCIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia
50. Hypertriglyceridemia as a result of human apoCIII gene expression in transgenic mice
51. Restriction fragment length polymorphisms associated with abnormal lipid levels in an adolescent population
52. Variation at the apolipoprotein AI/CIII/AIV gene complex is associated with elevated plasma levels of apoCIII
53. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia
54. Association of the SstI polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: The Framingham Offspring Study
55. Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese
56. Variations at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: Interaction between genotype, gender, and smoking status
57. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a welsh population
58. Relationship of abdominal adiposity and dyslipemic status in women with a common mutation in the lipoprotein lipase gene
59. HindIII DNA polymorphism in the lipoprotein lipase gene and plasma lipid phenotypes and carotid artery atherosclerosis
60. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: The Framingham Offspring Study
61. Characterization of the human lipoprotein lipase (LPL) promoter: Evidence of two cis-regulatory regions, lp-α and lp-β, of importance for the differentiation-linked induction of the LPL gene during adipogenesis
62. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: Studies in the fasting and the postprandial states: The European Atherosclerosis Research Studies
63. Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels
64. Common sequence variants of lipoprotein lipase: Standardized studies of in vitro expression and catalytic function
65. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients: The Ser447-Stop substitution in the lipoprotein lipase gene
66. 447stop mutation in lipoprotein lipase is associated with elevated hdl cholesterol levels in normolipidemic males
67. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase
68. Apolipoprotein E and lipoprotein lipase co-ordinately enhance binding and uptake of chylomicrons by human hepatocytes
69. Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort
70. Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose dependent manner
71. Association of apolipoprotein E genotype with plasma apoE levels
72. Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins
73. The intersection of genetics, public health, and preventive medicine